2026 William R. Sellers: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	132	2263	2105	1280	1172	305	104461

William R. Sellers publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where William R. Sellers sits on this spectrum.

101 publications 1,796+

This scientist: 305 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

William R. Sellers D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where William R. Sellers sits on this spectrum.

70 D-Index 217+

This scientist: 132 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

1873 - Member of the National Academy of Sciences
Member of the Association of American Physicians
Member of the Association of American Physicians

Overview

William R. Sellers is affiliated with Harvard University in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine, with a focus on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research, and Surgery.

The scientist's work covers several main topics, including:

Cancer-related gene regulation
Protein Degradation and Inhibitors
Epigenetics and DNA Methylation
Cancer Genomics and Diagnostics
Ubiquitin and proteasome pathways
Advanced Breast Cancer Therapies
Fibroblast Growth Factor Research

William R. Sellers has contributed multiple papers with notable publication venues and years:

Quantitative Proteomics of the Cancer Cell Line Encyclopedia, 2020, Cell
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer, 2020, Journal of Medicinal Chemistry
Targeting pan-essential genes in cancer: Challenges and opportunities, 2021, Cancer Cell
Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers, 2021, Nature Genetics
Molecular basis for substrate recruitment to the PRMT5 methylosome, 2021, Molecular Cell

Frequent coauthors include:

Devishi Kesar, with 14 joint publications
Diego J. Rodriguez, with 11 joint publications
Ruitong Li, with 9 joint publications
Kathleen M. Mulvaney, with 9 joint publications
Saireudee Chaturantabut, with 9 joint publications

Common publication venues where their work appears frequently consist of:

Cancer Research (21 publications)
bioRxiv (Cold Spring Harbor Laboratory) (7 publications)
Nature Genetics (3 publications)
Molecular Cancer Therapeutics (3 publications)
Cell (2 publications)

Among their recognized achievements are membership honors including:

Member of the National Academy of Sciences (1873)
Member of the Association of American Physicians

Best Publications

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

J. Guillermo Paez;Pasi A. Jänne;Pasi A. Jänne;Jeffrey C. Lee;Sean Tracy

11859
Citations
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Jordi Barretina;Giordano Caponigro;Nicolas Stransky;Kavitha Venkatesan

8025
Citations
The landscape of somatic copy-number alteration across human cancers

Rameen Beroukhim;Craig H. Mermel;Craig H. Mermel;Dale Porter;Guo Wei

4301
Citations
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Ross L. Levine;Ross L. Levine;Martha Wadleigh;Jan Cools;Benjamin L. Ebert;Benjamin L. Ebert

3760
Citations
Gene expression correlates of clinical prostate cancer behavior.

Dinesh Singh;Phillip G. Febbo;Phillip G. Febbo;Kenneth Ross;Donald G. Jackson

3146
Citations
Next-generation characterization of the Cancer Cell Line Encyclopedia

Mahmoud Ghandi;Franklin W. Huang;Franklin W. Huang;Franklin W. Huang;Judit Jané-Valbuena;Judit Jané-Valbuena;Gregory V. Kryukov

2674
Citations
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

Levi A. Garraway;Hans R. Widlund;Mark A. Rubin;Gad Getz

1805
Citations
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

Ingo K. Mellinghoff;Maria Y. Wang;Igor Vivanco;Daphne A. Haas-Kogan

1733
Citations
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

Cory M Johannessen;Jesse S. Boehm;So Young Kim;Sapana R. Thomas;Sapana R. Thomas

1698
Citations
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity

Sauveur-Michel Maira;Frédéric Stauffer;Josef Brueggen;Pascal Furet

1660
Citations
Molecular characterization of the tumor microenvironment in breast cancer

Minna Allinen;Rameen Beroukhim;Li Cai;Cameron Brennan

1574
Citations
BRAF mutation predicts sensitivity to MEK inhibition

David B. Solit;Levi A. Garraway;Levi A. Garraway;Christine A. Pratilas;Ayana Sawai

1546
Citations
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Hui Gao;Joshua M Korn;Stéphane Ferretti;John E Monahan

1349
Citations
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma

Rameen Beroukhim;Gad Getz;Leia Nghiemphu;Jordi Barretina

1263
Citations
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway

Isabelle Sansal;William R. Sellers

1232
Citations
High-throughput oncogene mutation profiling in human cancer

Roman K. Thomas;Alissa C. Baker;Ralph M. DeBiasi;Ralph M. DeBiasi;Wendy Winckler;Wendy Winckler

1183
Citations
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

Pradip K Majumder;Phillip G Febbo;Phillip G Febbo;Rachel Bikoff;Rachel Bikoff;Raanan Berger;Raanan Berger

1167
Citations
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties

William G. Kaelin;Wilhelm Krek;William R. Sellers;James A. DeCaprio

1059
Citations
Phosphorylation of the PTEN Tail Regulates Protein Stability and Function

Francisca Vazquez;Shivapriya Ramaswamy;Noriaki Nakamura;William R. Sellers

931
Citations
Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.

Máirín E. McMenamin;Peggy Soung;Sauni Perera;Irving Kaplan

920
Citations

Frequent Co-Authors

Levi A. Garraway Roche (United States)

Matthew Meyerson Harvard University

Rameen Beroukhim Harvard University

Todd R. Golub Harvard University

Heidi Greulich Broad Institute

Jordi Barretina Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

Massimo Loda Cornell University

Mark A. Rubin University of Bern

Pasi A. Jänne Harvard University

William G. Kaelin Harvard University

External Links

Personal website of William R. Sellers

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA can lead to many rewarding paths beyond traditional medical school. Many students explore related online degrees to build a strong foundation or to specialize further in the healthcare sector. For example, a nutrition bachelor degree online can provide valuable expertise in dietary science, health promotion, and disease prevention.

Advancing into healthcare management is also an option. Enrolling in online mha programs helps prepare individuals for leadership and administrative roles within hospitals, clinics, and public health organizations.

For registered nurses aiming to further their education, many are drawn to rn to bsn programs no clinicals. These online pathways allow nurses to expand their qualifications without the need for additional clinical hours, making it more convenient for working professionals.

Those targeting advanced practice and leadership positions can benefit from the shortest dnp programs, which fast-track doctoral-level nursing education. These online degrees offer flexibility and specialization, opening doors across healthcare disciplines.